Skip to main content

Advertisement

SpringerLink
Log in

Infliximab-Induced Autoimmune Hepatitis with Successful Switch to Adalimumab in a Patient with Crohn’s disease: The Index Case

  • Case Report
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Sokolove J, Strand V, Greenberg JD, et al. Risk of elevated liver enzymes associated with TNF inhibitor utilisation in patients with rheumatoid arthritis. Ann Rheum Dis. 2010;69:1612–1617.

    Article  PubMed  CAS  Google Scholar 

  2. Hennes EM, Zeniya M, Czaja AJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008;48:169–176.

    Article  PubMed  Google Scholar 

  3. Khokhar OS, Lewis JH. Hepatotoxicity of agents used in the management of inflammatory bowel disease. Dig Dis. 2010;28:508–518.

    Article  PubMed  Google Scholar 

  4. Mancini S, Amorotti E, Vecchio S, Ponz de Leon M, Roncucci L. Infliximab-related hepatitis: discussion of a case and review of the literature. Intern Emerg Med. 2010;5:193–200.

    Article  PubMed  Google Scholar 

  5. Haennig A, Bonnet D, Thebault S, Alric L. Infliximab-induced acute hepatitis during Crohn’s disease therapy: Absence of cross-toxicity with adalimumab. Gastroenterologie Clinique et Biologique. 2010;34:e7–e8.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Columbia University Graduate School of Arts and Sciences, New York, NY, USA

    Dahlia A. Goldfeld

  2. Division of Gastroenterology, Department of Medicine, Columbia University Medical Center, New York, NY, USA

    Elizabeth C. Verna & Arun Swaminath

  3. Department of Pathology, Columbia University Medical Center, New York, NY, 10032, USA

    Jay Lefkowitch

Authors
  1. Dahlia A. Goldfeld
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elizabeth C. Verna
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jay Lefkowitch
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Arun Swaminath
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Arun Swaminath.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Goldfeld, D.A., Verna, E.C., Lefkowitch, J. et al. Infliximab-Induced Autoimmune Hepatitis with Successful Switch to Adalimumab in a Patient with Crohn’s disease: The Index Case. Dig Dis Sci 56, 3386–3388 (2011). https://doi.org/10.1007/s10620-011-1748-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-011-1748-1

Keywords

Search

Navigation